Ledger.Open graph →
SEC Form D · filed October 10, 2017

Engage Therapeutics, Inc

Offering
$23.6M
Sold
$23.6M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SUMMIT, NJ
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Heath D. Lukatch · Fort Worth, TXDirectorVirginia Stallings · Exton, PADirectorCaledonia (Private) Investments Pty Limited · SYDNEY NSW, Channel IslandsExecDominik W. Pozny · New York, NYDirectorGerry D. Brunk · Weston, MADirectorSire Management Corporation · New York, NYDirectorOrrin Devinsky · New York, NYDirectorThomas Gravina · Exton, PAExec · Director · PromoterDavid Gastfriend · BOSTON, MAExecStephen D. Collins · Lake Forest, ILDirectorJouko D. Isojarvi · Durham, NCExecDavid Kittle · San Diego, CADirectorJames O'Connell · Exton, PADirectorRichard Vague · Exton, PADirectorSam Eletr · San Francisco, CADirectorSire Management Partners, L.P · New York, NYDirectorDouglas F. Blough · NASHUA, NHDirectorBruce S. Macdonald · NASHUA, NHExec · Director · PromoterFrederick Jones · Exton, PADirectorWarren Lammert · Boston, MADirectorGregory Mayes · Summit, NJExec · Director · Promoter

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗